Forex
World
Market
Business
Cryptocurrency
Commodities
MAP
Publish for free
Business
financetom
/
Business
/
--Caleres Keeps Regular Quarterly Cash Dividend at $0.07 a Share, Payable April 12 to Holders of Record March 28
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
Forex
Stocks Market
Commodities
--Caleres Keeps Regular Quarterly Cash Dividend at $0.07 a Share, Payable April 12 to Holders of Record March 28
Mar 14, 2024 2:56 PM
05:38 PM EDT, 03/14/2024 (MT Newswires) --
Price: 38.5, Change: +0.16, Percent Change: +0.42
Previous page:
Getty Images Stock Climbs On Better-Than-Expected Q4 Revenue Results
Next page:
Madrigal Pharmaceuticals Gets FDA Approval for Liver Fibrosis Therapy
Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Release time ⇩
Release time ⇧
Like count ⇩
Show More Comments
Related Articles >
Getty Images Stock Climbs On Better-Than-Expected Q4 Revenue Results
Mar 14, 2024
Getty Images Holdings Inc. ( GETY ) reported its fourth-quarter financial results after the bell Thursday. Here's a look at the details. The Details: The company reported quarterly sales of $225.94 million which beat the analyst consensus estimate of $216.46 million by 4.38% and is a 2.39% decrease over sales of $231.47 million from the same period last year. Getty...
Madrigal Pharmaceuticals Gets FDA Approval for Liver Fibrosis Therapy
Mar 14, 2024
05:36 PM EDT, 03/14/2024 (MT Newswires) -- Madrigal Pharmaceuticals ( MDGL ) received the US Food and Drug Administration's accelerated approval of Rezdiffra for treating adults with noncirrhotic nonalcoholic steatohepatitis and moderate to advanced liver fibrosis, the company said Thursday. Rezdiffra, which is a once-daily oral therapy, was approved in combination with diet and exercise, the company said. The approval...
--Caleres Keeps Regular Quarterly Cash Dividend at $0.07 a Share, Payable April 12 to Holders of Record March 28
Mar 14, 2024
05:38 PM EDT, 03/14/2024 (MT Newswires) -- Price: 38.5, Change: +0.16, Percent Change: +0.42 ...
Nuvation Bio Doses First Patient in Phase 1/2 Study of Advanced Solid Tumor Treatment
Mar 14, 2024
05:38 PM EDT, 03/14/2024 (MT Newswires) -- Nuvation Bio ( NUVB ) said late Thursday the first patient has been dosed in a phase 1/2 study of NUV-1511 to treat advanced solid tumors. The company said the study will initially evaluate safety and tolerability, pharmacokinetic profile, and assess for indications of clinical activity in patients with advanced solid tumors who...
About
Terms and Conditions
Privacy policy
Cookie Settings
Contact Us
Services
Login
register
financetom
Market
Personal Finance
Business
Economy
Cryptocurrency
MAP
Links
zpostcode
Recruit
weather
mreligion
Yellowpages
sport
constellation
shopping
name
game
directory
literature
Word
tour
furnish
Lottery
tftnews
lyrics
News
digital
car
dir
Edu
Finance
Copyright 2023-2026 -
www.financetom.com
All Rights Reserved
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
MAP